News | Treatment Planning | August 23, 2019

Heidelberg University Hospital Treats First Patient Using Carbon Ion Therapy With RayStation

German hospital plans to use RayStation for all proton and carbon ion therapy treatment planning, including helium ion therapy beginning in 2020

Heidelberg University Hospital Treats First Patient Using Carbon Ion Therapy With RayStation

August 23, 2019 — Heidelberg University Hospital, Germany, has started using the RayStation treatment planning system for carbon ion therapy treatments. The center is now using RayStation for both particle therapy and photon therapy.

In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital. An additional RayStation order for photon therapy was placed later that year, and RaySearch and Heidelberg University Hospital also entered into a long-term collaborative agreement regarding the clinical introduction of the RayCare oncology information system.

HIT has long expertise in advanced radiation therapy techniques and has been performing proton therapy and carbon ion therapy for the past 10 years. The center is now replacing its existing treatment planning system for protons and carbon ions and aims to use RayStation exclusively. Heidelberg University Hospital also treats patients using TomoTherapy, which is the focus of another cooperation between HIT and RaySearch. In addition, the center aims to begin treating patients using helium ion therapy by 2020. RayStation enables treatment planning for all of these modalities with a single software platform.

The HIT facility is an in-house medical product integrating a particle accelerator, a rotating ion gantry and an Iontris delivery system from Siemens Healthcare. The setup includes three treatment rooms, two horizontal treatment rooms,  and one gantry for both carbon ion and proton therapy. The gantry is the world’s first for carbon ion therapy. The facility has the capacity to treat up to 1,000 patients per year using particle therapy.

Jürgen Debus, professor and chairman, radiation oncology at Heidelberg University Hospital, said, “Carbon ion treatment planning in RayStation offers us unique options to optimize our treatment plans along with proton and photon precision radiotherapy.”

For more information: www.raysearchlabs.com

Related Content

Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s
High-intensity focused ultrasound (HIFU), a technology used to treat localized prostate cancer, has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in The Journal of Urology, Official Journal of the American Urological Association

Getty Images

News | Prostate Cancer | September 08, 2020
September 8, 2020 — Approved by the US Food and Drug Administration (FDA) in 2015 for prostate tissue ablation, the h
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer